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Brain microenvironment plays important roles in neurodevelopment and pathology and can affect therapy 
efficacy. Neural cell culture typically relies on the use of heterologous matrices that poorly resemble brain 
extracellular matrix (ECM) or reflect its pathological features. We have shown that perfusion bioreactor-based 
3D differentiation of iPSC-derived human neural stem cells (hiPSC-NSC) sustains the concomitant 
differentiation of the three neural lineages (neurospheroids). If this neurospheroid culture strategy also allows 
deposition of native neural ECM it would be possible to (i) mimic cellular and microenvironment remodeling 
during neural differentiation, without the confounding effects of exogenous matrices and (ii) recapitulate 
pathological phenotypic features of diseases in which homotypic/ heterotypic cell-cell interactions and ECM are 
relevant. To characterize the neural extracellular space we employed quantitative transcriptomic (NGS) and 
proteome (SWATH-MS) analysis. Neurogenic developmental pathways were recapitulated in neurospheroids, 
with significant changes in cell membrane and ECM composition along differentiation; a significant enrichment in 
structural proteoglycans, typical of brain ECM, a downregulation of basement membrane proteins constituents 
and a higher expression of synaptic and ion transport machinery were observed. Neurospheroids were 
generated using hiPSC-NSC derived from Mucopolysaccharidosis type VII (MPS VII) patients. MPS VII is a rare 
neuronopathic lysosomal storage disease caused by deficient β-glucuronidase (β-gluc) activity, leading to 
glycosaminoglycan (GAGs) accumulation in the brain. The main MPS VII molecular hallmarks were 
recapitulated, e.g. accumulation og GAGs. By combining the neurospheroid culture with a 3D neuronal 
connectivity assay based on calcium imaging analysis we refined a new analytical strategy to characterize 
neuronal connectivity defects in a more predictive setting. We showed that MPS VII neurospheroids presented 
reduced neuronal activity and disturbances in network functionality, with alterations in connectivity and 
synchronization. These data provide insights into the interplay between reduced β-gluc activity, GAGs 
accumulation, alterations in neuronal network and its impact on MPS VII-associated cognitive defects Applying 
the characterization tools refined in this work to cope with 3D neurospheroid cultures, namely the neuronal 
connectivity assay, we provide a new platform to unveil the cellular processes responsible for brain dysfunction 
in neurological disorders and to test and optimize new therapies. 
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